Literature DB >> 34024041

Management of Acute Appendicitis during the COVID-19 Pandemic: A Single Tertiary Center Experience.

Mor Aharoni1,2, Yiftach Barash1,3,2, Yaniv Zager1,2, Roi Anteby1,3,2, Saed Khalilieh1,2, Imri Amiel1,3,2, Eyal Klang1,3,2, Yuri Goldes1,2, Mordechai Gutman1,2, Nir Horesh1,2, Danny Rosin1,3,2.   

Abstract

BACKGROUND: The coronavirus disease-2019 (COVID-19) outbreak had an effect on healthcare.
OBJECTIVES: To evaluate the presentation and management of patients with acute appendicitis.
METHODS: A retrospective study was conducted of all patients presenting with acute appendicitis to the emergency department of a large tertiary center during March and April 2020. Clinical features, diagnostic workup, and management were compared.
RESULTS: Seventy-four patients presented with acute appendicitis during the pandemic compared to 60 patients during the same time the year before. There were no significant differences in patient demographics: age (P = 0.65), gender (P = 0.73), smoking status (P = 0.48). During COVID-19 patients were more likely to complain of right lower quadrant pain (100% vs. 78.3%, P < 0.01). Rates of surgical treatment was similar (83.8% vs. 81.7%, P = 1); mean operative time was longer during COVID-19 (63 ± 23 vs. 52 ± 26 minutes, P = 0.03). There were no significant differences in intra-operative findings including the presence of appendiceal perforation (16.3% vs. 14.5%, P = 0.8), abscess (6.1% vs. 9.7%, P = 0.73), or involvement of cecum or terminal ileum (14.28% vs. 19.63%, P = 1). Postoperative treatment with antibiotics was more prevalent during COVID-19 (37.1% vs. 18%, P = 0.04). Length of stay (1.82 ± 2.04 vs. 2.74 ± 4.68, P = 0.2) and readmission rates (6% vs. 11.3%, P =0.51) were similar.
CONCLUSIONS: The COVID-19 pandemic did not significantly affect the presentation, clinical course, management, and outcomes of patients presenting with acute appendicitis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34024041

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

Review 1.  Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses.

Authors:  Vahid Mogharab; Mahshid Ostovar; Jakub Ruszkowski; Syed Zohaib Maroof Hussain; Rajeev Shrestha; Uzair Yaqoob; Poorya Aryanpoor; Amir Mohammad Nikkhoo; Parasta Heidari; Athar Rasekh Jahromi; Esmaeil Rayatdoost; Anwar Ali; Farshid Javdani; Roohie Farzaneh; Aref Ghanaatpisheh; Seyed Reza Habibzadeh; Mahdi Foroughian; Sayyed Reza Ahmadi; Reza Akhavan; Bita Abbasi; Behzad Shahi; Arman Hakemi; Ehsan Bolvardi; Farhad Bagherian; Mahsa Motamed; Sina Taherzadeh Boroujeni; Sheida Jamalnia; Amir Mangouri; Maryam Paydar; Neda Mehrasa; Dorna Shirali; Francesco Sanmarchi; Ayesha Saeed; Narges Azari Jafari; Ali Babou; Navid Kalani; Naser Hatami
Journal:  Global Health       Date:  2022-06-08       Impact factor: 10.401

2.  Impact of COVID-19 on the incidence of CT-diagnosed appendicitis and its complications in the UK and Sweden.

Authors:  Michael R Torkzad; Arnar Thorisson; Abbas Chabok; Maziar Nikberg; Roland E Andersson; Fausto Labruto
Journal:  Int J Colorectal Dis       Date:  2022-05-16       Impact factor: 2.796

3.  Characteristics of Acute Appendicitis before and during the COVID-19 Pandemic: Single Center Experience.

Authors:  A Bosak Veršić; M Šestan; I Ćepić; H Nikolić; N Bukvić; S Sršen Medančić; D Hasandić; M Zelić
Journal:  Emerg Med Int       Date:  2022-02-24       Impact factor: 1.112

4.  Feasibility of safe laparoscopic surgery performed by junior residents without exposure of open appendectomy: A retrospective study.

Authors:  Satya Prakash Meena; Mayank Badkur; Mahaveer S Rodha; Mahendra Lodha; Ashok Puranik; Krashan Kant Premi
Journal:  J Family Med Prim Care       Date:  2022-02-16

5.  Impact of the COVID-19 pandemic on the severity and management of acute appendicitis.

Authors:  Marion Poget; Roland Chautems; Rémy Kohler; Michele Diana; Alend Saadi
Journal:  Front Surg       Date:  2022-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.